Neoepitope BTLAP267L-specific TCR-T cell immunotherapy unlocks precision treatment for hepatocellular carcinoma

Neoepitope BTLAP267L-specific TCR-T cell immunotherapy unlocks precision treatment for hepatocellular carcinoma

Objective: The high heterogeneity of hepatocellular carcinoma (HCC) renders traditional therapies unable to effectively activate the patient’s immune system to combat tumors. Patients with advanced HCC and T cell functional deficiencies may benefit more from cellular immunotherapy, especially tumor...

Full description

Saved in:
Bibliographic Details
Main Authors: Fang Liu, Hua Chen, Suxin Wu, Chenlu Zhu, Mingji Zhang, Wei Rui, Dong Zhou, Yang Wang, Xin Lin, Xueqiang Zhao, Yunbin Ye
Format: Article
Language:English
Published: China Anti-Cancer Association 2025-04-01
Series:Cancer Biology & Medicine
Subjects:
neoepitope
t cell receptor-t cell
immunotherapy
hepatocellular carcinoma
Online Access:https://www.cancerbiomed.org/content/22/4/412
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.cancerbiomed.org/content/22/4/412

Similar Items